Effects of PKCalpha activation on Ca2+ pump and KCa channel in deoxygenated sickle cells

We have previously shown that a pretreatment with phorbol12-myristate 13-acetate (PMA), an activator of protein kinase C (PKC),reduced deoxygenation-induced K⁺loss and Ca²⁺ uptake and preventedcell dehydration in sickle anemia red blood cells (SS cells) (H. Fathallah, E. Coezy, R.-S. De Neef, M.-D. Hardy-Dessources, and F. Giraud. Blood 86: 1999-2007,1995). The present study explores the detailed mechanism of thisPMA-induced inhibition. The main findings are, first, the detection ofPKC and PKC in normal red blood cells and the demonstration that both isoforms are expressed at higher levels in SS cells. The -isoform only is translocated to the membrane and activated by PMAand by elevation of cytosolicCa²⁺. Second, PMA is demonstratedto activate Ca²⁺ efflux indeoxygenated SS cells by a direct stimulation of the Ca²⁺ pump. PMA, moreover, inhibitsdeoxygenation-induced, charybdotoxin-sensitive K⁺ efflux in SS cells. Thisinhibition is partly indirect and explained by the reduceddeoxygenation-induced rise in cytosolicCa²⁺ resulting fromCa²⁺ pump stimulation. However, asignificant inhibition of theCa²⁺-activatedK⁺ channels(K_Ca channels) by PMA can also bedemonstrated when the channels are activated byCa²⁺ plus ionophore, underconditions in which the Ca²⁺ pumpis operating near its maximal extrusion rate, but swamped byCa²⁺ plus ionophore. The data thussuggest a PKC-mediated phosphorylation both of theCa²⁺ pump and of theK_Ca channel or an auxiliaryprotein.